Skip to main content
Equibles
BDX logo

BDX · Becton Dickinson & Co · Metrics

Track BDX — free

Use BDX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BDX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$198.91 -1.51 (-0.75%) At close · Oct 23
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$54.16B
Shares
272.39M
Volume · Oct 23 1.3M Avg daily vol (3M) 1.74M

BDX metrics

101 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$198.91
Market cap
$54.16B

Price action

20 metrics
Price change (1W)
+3.7%
Price change (30D)
+9.0%
Price change (3M)
+27.2%
Price change (6M)
+30.7%
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
27.1%
Annualized volatility (3M)
25.1%
Beta
0.3
RSI (14D)
68.9
Price vs SMA 50
+7.3%
Price vs SMA 200
—
Avg volume (3M)
1.74M
Relative volume
0.8
Average dollar volume
$316.02M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
272.39M

Valuation

12 metrics
P / E (TTM)
99.4
Trailing earnings · reciprocal yield 1.0%
PEG ratio
—
EV / revenue
3.1×
reciprocal yield 31.9%
EV / EBITDA
14.7×
reciprocal yield 6.8%
EV / EBIT
30.4×
reciprocal yield 3.3%
P / sales
2.4×
reciprocal yield 41.4%
P / book
2.2
reciprocal yield 45.1%
FCF yield
5.9%
TTM · current market cap
Buyback yield
4.6%
P / FCF
16.9
reciprocal yield 5.9%
P / operating cash flow
13.7
reciprocal yield 7.3%
Earnings yield
1.7%

Historical valuation

8 metrics
P / E historical average (3Y)
43.8×
reciprocal yield 2.3%
P / E historical average (5Y)
43.3×
reciprocal yield 2.3%
EV / revenue historical average (3Y)
3.7×
reciprocal yield 27.0%
EV / revenue historical average (5Y)
4.0×
reciprocal yield 24.8%
EV / EBIT historical average (3Y)
33.4×
reciprocal yield 3.0%
EV / EBIT historical average (5Y)
34.7×
reciprocal yield 2.9%
EV / EBITDA historical average (3Y)
16.2×
reciprocal yield 6.2%
EV / EBITDA historical average (5Y)
17.5×
reciprocal yield 5.7%

Dividends & buybacks

7 metrics
Dividend yield
2.0%
Trailing 12 months
Payout ratio
124.5%
Shareholder yield
6.8%
Dividend / share (TTM)
$3.98
Dividend growth YoY
+21.6%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-09-09

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
46.7%
Operating margin
10.3%
Trailing 12 months
Net margin
4.2%
Gross profit (TTM)
$10.47B
Operating profit (TTM)
$2.31B
Net income (TTM)
$941.00M
Trailing 12 months
Diluted EPS (TTM)
$2.00
FCF margin
14.3%
Effective tax rate
12.7%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$89.64

Growth

11 metrics
Revenue growth YoY
+5.4%
Year over year
Net income growth YoY
-34.3%
Revenue (TTM)
$22.41B
Trailing 12 months
EPS growth YoY
-31.5%
Shares change YoY
-4.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+5.0%
Revenue CAGR (5Y)
+6.3%
EPS CAGR (3Y)
-0.3%
EPS CAGR (5Y)
+16.5%
FCF CAGR (3Y)
+21.2%
FCF CAGR (5Y)
-0.7%

Quality

14 metrics
Return on equity
3.9%
Return on assets
1.9%
Debt / equity
0.7
Current ratio
0.9
EBITDA (TTM)
$4.77B
Free cash flow (TTM)
$3.20B
Quick ratio
0.5
Interest coverage
3.9
Net debt / EBITDA
3.4
Return on invested capital
5.0%
Trailing 12 months
Net cash
−$16.10B
Latest balance sheet
Cash & equivalents
$708.00M
Total assets
$50.73B
Total debt
$16.81B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$3.96B
Capital expenditures (TTM)
$753.00M
R&D (TTM)
$1.27B
SG&A (TTM)
$5.55B
Stock compensation (TTM)
$283.00M
R&D / revenue
5.7%
Stock compensation / revenue
1.3%

Ownership (13F)

9 metrics
13F filers
1,456
13F filer change QoQ
-28
Institutional ownership
97.4%
Conviction holders (share of 13F filers)
0.7%
Crowding (high-turnover and private-fund holders)
21.0%
Private-fund adviser ownership
20.8%
Active holders' share change QoQ
-0.9%
Holder tenure
17.6
Price vs estimated holder cost
-2.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
22.7%

Short interest

3 metrics
Short interest
3.6%
Latest settlement · 4.9 days to cover
Days to cover
4.9d
Short-squeeze score
52 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.27M
Insider-sentiment score
50 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 10795 CUSIP 075887109 13F (30d) 379 filings 355 filers Visit website Investor relations